Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Jelić, Svetislav B."'
Autor:
Nikolić Ljubinka I., Nedeljković Ninoslav D., Jelić Svetislav B., Suvajdžić Vuković Nada D., Fillipović-Lješković Ivana M., Marković Srđan Z., Janković Drina Lj., Kastratović Dragana A.
Publikováno v:
Hospital Pharmacology, Vol 2, Iss 3, Pp 297-307 (2015)
Introduction: Serious adverse event of anticancer chemotherapy is glanulocytopenia and thrombocytopenia which can decrease efficiency of final therapy results. After many years, platelet concentrates transfusion (PCT) is still researching problem wit
Externí odkaz:
https://doaj.org/article/765680fc81ba4ae3b64eb3624cf25bc1
Publikováno v:
Srpski Arhiv za Celokupno Lekarstvo, Vol 132, Iss 3-4, Pp 73-75 (2004)
Appropriate management of patients with supraglottic laryngeal carcinoma and negative findings in the neck is still controversial. A prospective and retrospective study comprised 193 patients who were treated primary surgically between 1976 and 1993.
Externí odkaz:
https://doaj.org/article/4f325d8183ff4ec99a012ed647e7a8aa
Publikováno v:
Archive of Oncology, Vol 11, Iss 3, Pp 165-167 (2003)
For almost 40 years, the only option for patients with unresectable metastases was treatment with 5-fluorouracil. In the last decade, new drugs became available that changed attitude toward treatment of metastatic CRC as well as the prognosis for som
Externí odkaz:
https://doaj.org/article/2e53572fd5de42ba9cae4b32bd068958
Publikováno v:
Archive of Oncology, Vol 11, Iss 3, Pp 157-159 (2003)
Gastric carcinoma is a frequent malignancy throughout the world and endemic in many of its regions. Advanced gastric carcinoma is often diagnosed. Patients with advanced gastric cancer have a median survival of 6-8 months and chemotherapy is palliati
Externí odkaz:
https://doaj.org/article/df7c3cc5a0cd41c295c85cd19e1e2ea5
Publikováno v:
Archive of Oncology, Vol 11, Iss 3, Pp 161-163 (2003)
Adjuvant chemotherapy has been established as the standard of care for patients with node-positive resected colon cancer. 5-fluorouracil modulated with leucovorin given for six months is currently the most widely accepted "standard" regimen. The role
Externí odkaz:
https://doaj.org/article/5010036a08d64451966bd8bdf770155a
Publikováno v:
Archive of Oncology, Vol 10, Iss 3, Pp 135-137 (2002)
Externí odkaz:
https://doaj.org/article/076c6d65923341d7bbc2f440a6c3a719
Autor:
Jelić Svetislav B.
Publikováno v:
Archive of Oncology, Vol 10, Iss 3, Pp 133-135 (2002)
Externí odkaz:
https://doaj.org/article/439145f3ad224305ba4b4873d0073994
Autor:
Jelić Svetislav B.
Publikováno v:
Archive of Oncology, Vol 12, Iss 3, Pp 177-178 (2004)
Externí odkaz:
https://doaj.org/article/5121b2fad6ea423fa924bdcbd2ff8994
Publikováno v:
Archive of Oncology, Vol 10, Iss 3, Pp 217-218 (2002)
Externí odkaz:
https://doaj.org/article/80269fec002340219e96d53d26f180aa
Publikováno v:
Archive of Oncology, Vol 10, Iss 3, Pp 132-133 (2002)
Externí odkaz:
https://doaj.org/article/21cb061fa7444cefb5fa431e2fb2ac42